BG103997A - Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението - Google Patents
Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощениетоInfo
- Publication number
- BG103997A BG103997A BG103997A BG10399799A BG103997A BG 103997 A BG103997 A BG 103997A BG 103997 A BG103997 A BG 103997A BG 10399799 A BG10399799 A BG 10399799A BG 103997 A BG103997 A BG 103997A
- Authority
- BG
- Bulgaria
- Prior art keywords
- viral
- treatment
- methods
- east
- syndrome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/874,425 US5935597A (en) | 1995-12-15 | 1997-06-13 | Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
| PCT/US1998/011956 WO1998056325A1 (en) | 1997-06-13 | 1998-06-09 | Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103997A true BG103997A (bg) | 2001-07-31 |
Family
ID=25363728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103997A BG103997A (bg) | 1997-06-13 | 1999-12-13 | Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP1011567A4 (pl) |
| JP (1) | JP4531141B2 (pl) |
| KR (1) | KR20010013709A (pl) |
| CN (1) | CN1260703A (pl) |
| AP (1) | AP1629A (pl) |
| AR (1) | AR012970A1 (pl) |
| AU (1) | AU7831598A (pl) |
| BG (1) | BG103997A (pl) |
| BR (1) | BR9810095A (pl) |
| CA (1) | CA2295176A1 (pl) |
| CZ (1) | CZ298510B6 (pl) |
| EA (1) | EA200000011A1 (pl) |
| EE (1) | EE9900562A (pl) |
| ES (1) | ES2161187B1 (pl) |
| FI (1) | FI19992648L (pl) |
| GB (1) | GB2341319B (pl) |
| HU (1) | HUP0003034A2 (pl) |
| ID (1) | ID23516A (pl) |
| IL (2) | IL133396A0 (pl) |
| IS (1) | IS5289A (pl) |
| LT (1) | LT4714B (pl) |
| LV (1) | LV12490B (pl) |
| NO (1) | NO996117L (pl) |
| NZ (1) | NZ501669A (pl) |
| OA (1) | OA11307A (pl) |
| PL (1) | PL196256B1 (pl) |
| RO (1) | RO121252B1 (pl) |
| SI (1) | SI20191A (pl) |
| SK (1) | SK172299A3 (pl) |
| TN (1) | TNSN98086A1 (pl) |
| TR (1) | TR200000540T2 (pl) |
| WO (1) | WO1998056325A1 (pl) |
| YU (1) | YU66099A (pl) |
| ZA (1) | ZA984649B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1638468T3 (pl) * | 2003-06-30 | 2008-01-31 | Alza Corp | Sposób powlekania mikrowystępów do przekłuwania skóry |
| WO2005053641A1 (en) * | 2003-12-05 | 2005-06-16 | Namibia Medical Investments (Pty) Limited | Patch |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
| US5534260A (en) * | 1989-02-23 | 1996-07-09 | University Of Utah | Percutaneous drug delivery system |
| US5028435A (en) * | 1989-05-22 | 1991-07-02 | Advanced Polymer Systems, Inc. | System and method for transdermal drug delivery |
| US5624912A (en) * | 1991-08-21 | 1997-04-29 | Burcoglu; Arsinur | Method of treating HIV infection and related secondary infections with defibrotide |
| ATE165345T1 (de) * | 1992-02-20 | 1998-05-15 | Merrell Pharma Inc | Sulfonsaeurederivate zur behandlung von viruserkrankungen |
| EP0966196A4 (en) * | 1995-12-15 | 2002-03-27 | Virodene Pharmaceutical Holdin | COMPOSITION FOR CRYOPRESERVATION OF ORGANS AND FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS |
-
1998
- 1998-05-29 ZA ZA9804649A patent/ZA984649B/xx unknown
- 1998-06-09 CA CA002295176A patent/CA2295176A1/en not_active Abandoned
- 1998-06-09 SK SK1722-99A patent/SK172299A3/sk unknown
- 1998-06-09 KR KR1019997011724A patent/KR20010013709A/ko not_active Withdrawn
- 1998-06-09 BR BR9810095-5A patent/BR9810095A/pt not_active Application Discontinuation
- 1998-06-09 AP APAP/P/1999/001708A patent/AP1629A/en active
- 1998-06-09 SI SI9820040A patent/SI20191A/sl unknown
- 1998-06-09 IL IL13339698A patent/IL133396A0/xx active IP Right Grant
- 1998-06-09 NZ NZ501669A patent/NZ501669A/en unknown
- 1998-06-09 JP JP50311899A patent/JP4531141B2/ja not_active Expired - Fee Related
- 1998-06-09 ES ES009950072A patent/ES2161187B1/es not_active Expired - Lifetime
- 1998-06-09 RO RO99-01313A patent/RO121252B1/ro unknown
- 1998-06-09 EA EA200000011A patent/EA200000011A1/ru unknown
- 1998-06-09 CZ CZ0447399A patent/CZ298510B6/cs not_active IP Right Cessation
- 1998-06-09 YU YU66099A patent/YU66099A/sh unknown
- 1998-06-09 TR TR2000/00540T patent/TR200000540T2/xx unknown
- 1998-06-09 AU AU78315/98A patent/AU7831598A/en not_active Abandoned
- 1998-06-09 WO PCT/US1998/011956 patent/WO1998056325A1/en not_active Ceased
- 1998-06-09 EP EP98926488A patent/EP1011567A4/en not_active Withdrawn
- 1998-06-09 ID IDW20000042A patent/ID23516A/id unknown
- 1998-06-09 PL PL338439A patent/PL196256B1/pl unknown
- 1998-06-09 CN CN98806085A patent/CN1260703A/zh active Pending
- 1998-06-09 GB GB9929189A patent/GB2341319B/en not_active Expired - Fee Related
- 1998-06-09 EE EEP199900562A patent/EE9900562A/xx unknown
- 1998-06-09 HU HU0003034A patent/HUP0003034A2/hu unknown
- 1998-06-11 AR ARP980102783A patent/AR012970A1/es not_active Application Discontinuation
- 1998-06-12 TN TNTNSN98086A patent/TNSN98086A1/fr unknown
-
1999
- 1999-12-08 IS IS5289A patent/IS5289A/is unknown
- 1999-12-09 IL IL133396A patent/IL133396A/en not_active IP Right Cessation
- 1999-12-09 FI FI992648A patent/FI19992648L/fi unknown
- 1999-12-10 NO NO996117A patent/NO996117L/no not_active Application Discontinuation
- 1999-12-10 OA OA9900279A patent/OA11307A/en unknown
- 1999-12-13 BG BG103997A patent/BG103997A/xx unknown
- 1999-12-20 LT LT99-148A patent/LT4714B/lt not_active IP Right Cessation
-
2000
- 2000-02-02 LV LVP-99-182A patent/LV12490B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1151009T3 (da) | Antimikrobielt/endotoksin-neutraliserende polypeptid | |
| DE69734601D1 (de) | Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen | |
| ATE295176T1 (de) | Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen | |
| UA73115C2 (en) | Use of dipeptidyl peptidase iv inhibitors for treating short stature due to growth hormone deficiency | |
| DE69030880D1 (de) | Zusammensetzung zur Stimulierung des Immunsystems | |
| DE69734215D1 (de) | Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften | |
| ATE366312T1 (de) | Impfstoff und antitoxine zur behandlung und vorbeugung von c. difficile krankheiten | |
| ATE399562T1 (de) | Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen | |
| DE69631381D1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
| DE69929616D1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| BG103997A (bg) | Средство за трансдермално въвеждане терапевтичен агент и методи за лечение на вирусни и бактериалниинфекции и синдрома на изтощението | |
| DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
| UA49789C2 (uk) | Застосування димеру лізоциму як лікарського засобу для інгібування біосинтезу фактора некрозу пухлини, спосіб лікування та профілактики захворювань (варіанти), фармацевтична композиція (варіанти), застосування димеру лізоциму як лікарського засобу для профілактики або лікування сніду | |
| Rosenberg et al. | Antibiotic TA: an adherent antibiotic | |
| SE9700244D0 (sv) | Novel antibacterial protein | |
| DK0950416T3 (da) | Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse | |
| RU2179846C2 (ru) | Средство для профилактики и лечения желудочно-кишечных и респираторных заболеваний телят | |
| SU1629062A1 (ru) | Способ лечени колибактериоза тел т | |
| RU2709841C1 (ru) | Способ стимуляции репаративных процессов у животных после остеосинтеза | |
| EA199700353A1 (ru) | Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции | |
| FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida | |
| DK1150981T3 (da) | Terapeutisk necleosidforbindelse | |
| FI972121A0 (fi) | Sammansaettningar foer reciprok oekning av immunosupperssanters och interferoners farmaceutiska aktiviteter | |
| DE60134881D1 (de) | Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen | |
| JPS62155221A (ja) | 腫瘍壊死因子誘起用キツト |